These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 10449665)
21. Comparison of clinical characteristics of patients with follicular thyroid carcinoma and Hürthle cell carcinoma. Ernaga Lorea A; Migueliz Bermejo I; Anda Apiñániz E; Pineda Arribas J; Toni García M; Martínez de Esteban JP; Insausti Serrano AM Endocrinol Diabetes Nutr (Engl Ed); 2018 Mar; 65(3):136-142. PubMed ID: 29433918 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in patients with Hürthle cell neoplasms of the thyroid. Lopez-Penabad L; Chiu AC; Hoff AO; Schultz P; Gaztambide S; Ordoñez NG; Sherman SI Cancer; 2003 Mar; 97(5):1186-94. PubMed ID: 12599224 [TBL] [Abstract][Full Text] [Related]
23. Thyroid bed fine needle aspiration in patients after thyroidectomy--a useful follow-up tool with proposed diagnostic categories. Webster N; Fox C; Fan F Ann Diagn Pathol; 2014 Jun; 18(3):177-80. PubMed ID: 24768495 [TBL] [Abstract][Full Text] [Related]
24. [Loco-regional persistence and recurrences of operated differentiated thyroid cancers. 22 cases on 589 treated patients from 1964 to 1990, follow-up from 5 to 31 years]. Proye C; Gontier A; Capuano G; Combemale F; Carnaille B; Decoulx M; Wemeau JL; Lecomte-Houcke M Ann Endocrinol (Paris); 1997; 58(3):233-9; discussion 240-1. PubMed ID: 9239247 [TBL] [Abstract][Full Text] [Related]
25. Follicular or Hürthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? McHenry CR; Thomas SR; Slusarczyk SJ; Khiyami A Surgery; 1999 Oct; 126(4):798-802; discussion 802-4. PubMed ID: 10520931 [TBL] [Abstract][Full Text] [Related]
26. [Management and prognostic factors for 119 patients with follicular thyroid carcinoma]. Liu WS; Zhang GF; Xu ZG Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):778-82. PubMed ID: 24378102 [TBL] [Abstract][Full Text] [Related]
27. Occult distant metastases of well-differentiated thyroid carcinoma. Zohar Y; Strauss M Head Neck; 1994; 16(5):438-42. PubMed ID: 7960741 [TBL] [Abstract][Full Text] [Related]
28. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data. Kim WG; Kim TY; Kim TH; Jang HW; Jo YS; Park YJ; Kim SW; Kim WB; Shong M; Park DJ; Chung JH; Shong YK; Cho BY Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067 [TBL] [Abstract][Full Text] [Related]
30. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma. Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784 [TBL] [Abstract][Full Text] [Related]
31. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114 [TBL] [Abstract][Full Text] [Related]
32. Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas. Agha A; Glockzin G; Woenckhaus M; Dietmaier W; Iesalnieks I; Schlitt HJ Langenbecks Arch Surg; 2007 Nov; 392(6):671-7. PubMed ID: 17216284 [TBL] [Abstract][Full Text] [Related]
33. Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Chen H; Nicol TL; Zeiger MA; Dooley WC; Ladenson PW; Cooper DS; Ringel M; Parkerson S; Allo M; Udelsman R Ann Surg; 1998 Apr; 227(4):542-6. PubMed ID: 9563543 [TBL] [Abstract][Full Text] [Related]
34. Surgery for thyroid carcinoma. Starnes HF; Brooks DC; Pinkus GS; Brooks JR Cancer; 1985 Mar; 55(6):1376-81. PubMed ID: 3971307 [TBL] [Abstract][Full Text] [Related]
36. Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic significance of histologic vascular invasion in papillary and follicular thyroid carcinomas. Furlan JC; Bedard YC; Rosen IB J Am Coll Surg; 2004 Mar; 198(3):341-8. PubMed ID: 14992733 [TBL] [Abstract][Full Text] [Related]
38. Operative and postoperative management of the patient with follicular and Hürthle cell carcinoma. Do they differ? Grant CS Surg Clin North Am; 1995 Jun; 75(3):395-403. PubMed ID: 7747248 [TBL] [Abstract][Full Text] [Related]
39. [Hürthle cell carcinoma of the thyroid. A 41 years experience]. Sanz J; Cerpa F; Domínguez M; Franco C; Jadresic A; Pérez G; Phillipi V Rev Med Chil; 1999 Jul; 127(7):821-6. PubMed ID: 10668290 [TBL] [Abstract][Full Text] [Related]
40. Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer. Wang C; Chen X; Wei X; Chen F; Wang Y; Shen Z Asian J Surg; 2017 Jan; 40(1):55-60. PubMed ID: 27697309 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]